Key result
The authors question the necessity of corticosteroid therapy for amiodarone-induced pulmonary toxicity, suggesting the underlying process may be metabolic rather than immunologic.
Why the study?
Does corticosteroid therapy improve reversal of pulmonary injury compared to discontinuing amiodarone alone in patients with amiodarone pulmonary toxicity?
Population
Patients with amiodarone pulmonary toxicity
Comparison
Corticosteroid therapy vs Discontinuing amiodarone alone
Design
Editorial
Authors
Loading...
This letter questions whether corticosteroid therapy provides additional clinical benefit beyond simply discontinuing the drug for amiodarone-induced pulmonary toxicity.
Does corticosteroid therapy improve reversal of pulmonary injury compared to discontinuing amiodarone alone in patients with amiodarone pulmonary toxicity?
This letter questions whether corticosteroid therapy provides additional clinical benefit beyond simply discontinuing the drug for amiodarone-induced pulmonary toxicity.
Dake et al. (1983) conducted a letter in Amiodarone pulmonary toxicity. Corticosteroid therapy vs. Discontinuing amiodarone alone was evaluated. The authors question the necessity of corticosteroid therapy for amiodarone-induced pulmonary toxicity, suggesting the underlying process may be metabolic rather than immunologic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: